This scoping review compiled information concerning digital health technologies (DHTs)
evolution to support primary health care (PHC) during COVID-19 and lessons for the future …

This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …

Background Drug prohibition has been associated with increased risk of overdose.
However, drug prohibition remains the dominant drug policy, including in Canada with the …

Aim This research aimed to describe how the characteristics of deaths following drug use
changed during the COVID-19 pandemic in England, and how this can inform future strategy …

Following the emergence of SARS-CoV-2, various reports suggest that there has been a
significant increase in substance abuse due to social distancing and related issues. Several …

Background The excessive covid-related mortality of psychiatric patients was reduced by
vaccination. The vaccine uptake in patients diagnosed with different mental health disorders …

The fast, exponential increase of COVID-19 infections and their catastrophic effects on
patients' health have required the development of tools that support health systems in the …

Background: In this study, we determined the impact of the COVID-19 pandemic on Western
Sydney patients with substance use disorders (SUD) by comparing emergency department …

Background COVID-19 vaccination is crucial to reduce the incidence of severe forms of the
disease in the population. However, people who use drugs (PWUD) face structural and …

This study seminally uncovers that the vaccination rate among PWUDs was about 79.34% in
one district of Chengdu City, Sichuan Province, China. Assuming that unvaccinated PWUDs …